Takeda Files 6-K Report for June 2025
Ticker: TKPHF · Form: 6-K · Filed: Jun 2, 2025 · CIK: 1395064
| Field | Detail |
|---|---|
| Company | Takeda Pharmaceutical Co Ltd (TKPHF) |
| Form Type | 6-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, routine-disclosure
TL;DR
Takeda filed its monthly 6-K report on June 2, 2025, confirming its 20-F reporting status.
AI Summary
Takeda Pharmaceutical Company Limited filed a Form 6-K on June 2, 2025, reporting as a foreign private issuer for the month of June 2025. The filing indicates Takeda is submitting its annual reports under Form 20-F and is not submitting the 6-K in paper format. The document is a standard report of foreign private issuer information.
Why It Matters
This filing is a routine disclosure for Takeda as a foreign private issuer, providing updates and confirming its reporting status with the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain material financial or operational news.
Key Players & Entities
- Takeda Pharmaceutical Company Limited (company) — Filer
- 001-38757 (company) — SEC File Number
- 20250602 (date) — Filing Date
- June 2025 (date) — Reporting Period
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the registrant makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
Which form does Takeda use for its annual reports?
Takeda indicates it files its annual reports under cover of Form 20-F.
What is Takeda's principal executive office address?
Takeda's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8668, Japan.
Is Takeda submitting this Form 6-K in paper format?
No, Takeda is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
What is the SEC file number for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited's SEC file number is 001-38757.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding TAKEDA PHARMACEUTICAL CO LTD (TKPHF).